Kevin M Antshel1, Wanda Fremont2, Nancy J Roizen2, Robert Shprintzen2, Anne Marie Higgins2, Amit Dhamoon2, Wendy R Kates2. 1. Drs. Antshel, Fremont, Kates, and Mr. Dhamoon are with the Department of Psychiatry and Behavioral Sciences, Dr. Roizen is with the Department of Pediatrics, and Dr. Shprintzen and Ms. Higgins are with the Department of Otolaryngology and Communication Sciences, State University of New York Upstate Medical University, Syracuse; Dr. Kates is also with the Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore. Electronic address: AntshelK@upstate.edu. 2. Drs. Antshel, Fremont, Kates, and Mr. Dhamoon are with the Department of Psychiatry and Behavioral Sciences, Dr. Roizen is with the Department of Pediatrics, and Dr. Shprintzen and Ms. Higgins are with the Department of Otolaryngology and Communication Sciences, State University of New York Upstate Medical University, Syracuse; Dr. Kates is also with the Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore.
Abstract
OBJECTIVE: To examine prevalence rates of psychopathology in children with velocardiofacial syndrome (VCFS). METHOD: One hundred fifty-four children ages 6 to 15 participated in our between-group design with three samples, 84 children with VCFS (37 girls, 47 boys), 32 sibling controls (18 girls, 14 boys), and 38 community controls (12 girls, 26 boys). The Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime version and several other parent report measures were used to assess for psychopathology. RESULTS: Compared to both control samples, children with VCFS had higher prevalence rates of major depressive disorder, attention-deficit/hyperactivity disorder, simple phobias, and enuresis. Additional findings from our analyses include (1) no gender differences in VCFS psychopathology prevalence rates, (2) children with VCFS who have comorbid psychopathology were rated by their parents as having less well-developed executive functions, and (3) across all three samples, the higher the IQ was, the higher the level of global functioning. CONCLUSIONS: These findings are consistent with previous research and suggest that major depressive disorder, attention-deficit/hyperactivity disorder, and simple phobias are salient features of the VCFS psychiatric phenotype.
OBJECTIVE: To examine prevalence rates of psychopathology in children with velocardiofacial syndrome (VCFS). METHOD: One hundred fifty-four children ages 6 to 15 participated in our between-group design with three samples, 84 children with VCFS (37 girls, 47 boys), 32 sibling controls (18 girls, 14 boys), and 38 community controls (12 girls, 26 boys). The Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime version and several other parent report measures were used to assess for psychopathology. RESULTS: Compared to both control samples, children with VCFS had higher prevalence rates of major depressive disorder, attention-deficit/hyperactivity disorder, simple phobias, and enuresis. Additional findings from our analyses include (1) no gender differences in VCFS psychopathology prevalence rates, (2) children with VCFS who have comorbid psychopathology were rated by their parents as having less well-developed executive functions, and (3) across all three samples, the higher the IQ was, the higher the level of global functioning. CONCLUSIONS: These findings are consistent with previous research and suggest that major depressive disorder, attention-deficit/hyperactivity disorder, and simple phobias are salient features of the VCFS psychiatric phenotype.
Authors: Sunny X Tang; James J Yi; Tyler M Moore; Monica E Calkins; Christian G Kohler; Daneen A Whinna; Margaret C Souders; Elaine H Zackai; Donna M McDonald-McGinn; Beverly S Emanuel; Warren B Bilker; Ruben C Gur; Raquel E Gur Journal: J Am Acad Child Adolesc Psychiatry Date: 2014-06-19 Impact factor: 8.829
Authors: S X Tang; J J Yi; M E Calkins; D A Whinna; C G Kohler; M C Souders; D M McDonald-McGinn; E H Zackai; B S Emanuel; R C Gur; R E Gur Journal: Psychol Med Date: 2013-09-09 Impact factor: 7.723
Authors: Ehud Mekori-Domachevsky; Yael Guri; James Yi; Omri Weisman; Monica E Calkins; Sunny X Tang; Raz Gross; Donna M McDonald-McGinn; Beverly S Emanuel; Elaine H Zackai; Gil Zalsman; Abraham Weizman; Ruben C Gur; Raquel E Gur; Doron Gothelf Journal: Schizophr Res Date: 2016-12-29 Impact factor: 4.939
Authors: Wendy R Kates; Amy K Olszewski; Matthew H Gnirke; Zora Kikinis; Joshua Nelson; Kevin M Antshel; Wanda Fremont; Petya D Radoeva; Frank A Middleton; Martha E Shenton; Ioana L Coman Journal: Schizophr Res Date: 2014-07-25 Impact factor: 4.939
Authors: Mariken B de Koning; Esther D A van Duin; Erik Boot; Oswald J N Bloemen; Jaap A Bakker; Kathryn M Abel; Thérèse A M J van Amelsvoort Journal: Psychopharmacology (Berl) Date: 2015-06-12 Impact factor: 4.530